Hackensack Meridian Health Oncology

Liquid Biopsy
John Theurer Cancer Center at Hackensack University Medical Center Research Applies Best-in-Class Liquid Biopsy Technology for Patients with Myeloid Neoplasms

Study finds targeted NGS can reliably and efficiently provide enough information in one test on the blood to help refine diagnostics in AML and MDS

Three Year Follow Up
John Theurer Cancer Center at Hackensack University Medical Center Researchers Co-Author ZUMA-2 Three-Year Follow-Up on CAR T-Cell for Mantle Cell Lymphoma

Longest follow-up of CAR T-Cell in MCL to date showed long-term benefits for patients

CLL Therapy
Researchers at John Theurer Cancer Center at Hackensack University Medical Center Study CLL Retreatment with Venetoclax

Retrospective outcomes and safety data study opens potential for additional therapy after initial treatment with BTKi and venetoclax

Cancer Biomarker Studies
John Theurer Cancer Center at Hackensack University Medical Center Review Examines Exosomes as Source of Circulating Tumor Biomarkers

Exosomes produced by cancer cells evaluated for feasibility and potential as a minimally invasive liquid biopsy

Dual DNA
Hackensack University Medical Center Research Applies a Novel Platform of Dual DNA/RNA Signatures Using Liquid Biopsies for Patients with AML or MDS

Study finds targeted NGS can reliably and efficiently provide in one test enough information on the blood to help refine molecular diagnostic in AML and MDS

Prospective Cohort Study
John Theurer Cancer Center at Hackensack University Medical Center Research Demonstrates Increase in Early Onset Colorectal Cancer

Research contributes evidence of incidence increase under age 50

X
We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy.
Accept All Cookies